Millennium BioTherapeutics Inc. other research news

Millennium Bio reported the identification, cloning and initial characterization of a new chemokine, neurotactin, in humans

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE